Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.

Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be announcing earnings results this Tuesday ...

Key Insights Institutions' substantial holdings in Cardinal Health implies that they have significant influence ...

Healthcare earnings update: 93% of sector firms have reported, highlighting robust revenue growth & few misses.

Analysts expect the health care company to report quarterly earnings at $2.03 per share, up from $1.84 per share in the ...

Cardinal Health, Inc. (NYSE:CAH) will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug ...

U.S. stock futures are down, with earnings from Cardinal Health Inc. and Sea Ltd. to watch. ZipRecruiter Inc. beats ...

Schuyler County will receive up to $38,000 from a settlement with drug company Sandoz, Inc. and its affiliates over claims tied to the opioid crisis. The county legislature approved the settlement ...

Blackstone, Cinven, Thoma Bravo, TPG and Silver Lake were among the PE firms completing deals that stood out. While many ...

As companies expand their tech stacks and accelerate digital operations, they may be ignoring risks rooted in shadow systems, ...

Bloomberg's large-cap BMVP portfolio delivered positive returns in 2Q but trailed its benchmarks, held back by its defensive tilt during one of the fastest market rebounds on record.